Welcome to CDC stacks | Daily pill can prevent HIV : reaching people who could benefit from PrEP - 35760 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Daily pill can prevent HIV : reaching people who could benefit from PrEP
  • Published Date:
    11/24/2015
  • Language:
    English
Filetype[PDF-1.75 MB]


Details:
  • Corporate Authors:
    National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.)
  • Description:
    Preexposure prophylaxis (PrEP) is a medicine taken daily that can be used to prevent getting HIV. PrEP is for people without HIV who are at very high risk for getting it from sex or injection drug use. People at high risk who should be offered PrEP include about 1 in 4 sexually active gay and bisexual men, 1 in 5 people who inject drugs, and 1 in 200 sexually active heterosexual adults. When taken every day, PrEP is safe and highly effective in preventing HIV infection. PrEP is even more effective if it is combined with other ways to prevent new HIV infections like condom use, drug abuse treatment, and treatment for people living with HIV to reduce the chance of passing the virus to others. Many people who can benefit from PrEP aren’t taking it. If more health care providers know about and prescribe PrEP, more HIV infections could be prevented.

    Health care providers can:

    • Test patients for HIV as a regular part of medical care. Discuss HIV risks and continued use of prevention methods, including condom use, with all patients.

    • Follow the 2014 PrEP Clinical Practice Guidelines to perform recommended tests and prescribe PrEP to patients without HIV who could benefit.

    • Counsel patients who can benefit from PrEP on how to take it every day and help them apply for insurance or other programs to pay for PrEP.

    • Schedule appointments for patients using PrEP every 3 months for follow-up, including HIV testing and prescription refills.

    CS260440A

  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: